Dr. Jiang is the co-founder and CEO of Applied StemCell, Inc., a global leading company in stem cell and precise genome editing. Before co-founding Applied StemCell in 2008, Dr. Jiang was the General Manager of MicuRx (Shanghai) Pharmaceutical, Inc. a California‐based biopharmaceutical company where he set up its entire China operation. From 2005-2007, Dr. Jiang was head of the Pharmacogenetics Program at Stanford Research Institute International (SRI) where he managed pharmacogenetic and molecular genetics projects with multi‐ millions annual budget. Prior to relocating to California, Dr. Jiang served as senior scientist, then director of project management at Genaissance Pharmaceuticals from 2000‐2004 where he played an important role in biomarker discovery, pharmacogenetics and clinical bioinformatics, diagnostic product development, alliance management and business development.
Dr. Jiang received his B.S. degree in Biology from Fudan University, M.S. in Reproductive Biology from China Agricultural University and Ph.D. in Genetics from Oklahoma State University.
© Copyright AceLink Therapeutics. All rights reserved